The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trial
Patrick Meybohm(Universitätsklinikum Würzburg), Frank Bloos(Jena University Hospital), A. Weyland(Carl von Ossietzky Universität Oldenburg), Markus Loeffler(Leipzig University), Josef Briegel(LMU Klinikum), Axel Nierhaus(Universität Hamburg), Frank M. Brunkhorst, Gunnar Elke, Konrad Reinhart(Charité - Universitätsmedizin Berlin), Darius Cameron Wilson(BDH-Klinik Hessisch Oldendorf), Stefan Kluge(Universität Hamburg), Onnen Moerer(Universitätsmedizin Göttingen), Ulrich Jaschinski(University Hospital Augsburg)
Cited by 119
Related Papers
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008
|Intensive Care Medicine|2007|4.9k
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008
|Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna)|2008|3.9k
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
|Annals of Internal Medicine|2020|2.4k
Multiorgan and Renal Tropism of SARS-CoV-2
|New England Journal of Medicine|2020|1.9k